IONS vs OKUR · rev $514.0M vs P/E 72, rev $2.0M
Ionis Pharmaceuticals Inc (IONS) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
IONS currently screens at market cap $12.28B. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the IONS and OKUR stock pages for the full models.
Not investment advice.